Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation
- PMID: 7693843
Expression of the adipocyte fatty acid-binding protein in streptozotocin-diabetes: effects of insulin deficiency and supplementation
Abstract
The adipocyte fatty acid-binding protein, aP2 or ALBP, is an abundant cytosolic protein postulated to function in binding and intracellular transport of long-chain fatty acids. In this report, we investigated levels of aP2 mRNA and protein and transcriptional activity of the aP2 gene in tissues from streptozotocin-diabetic rats at different time periods following the induction of diabetes. An average 75% decrease in mRNA for aP2 (relative to mRNA for beta-actin) was observed in all diabetic rats at 7 days post-STZ injection. Insulin supplementation rapidly (2 h) restored aP2 mRNA and the insulin effect was cycloheximide-sensitive. Nuclear transcription assays measured a 60% decrease in transcription of the aP2 gene in diabetic rats that was reversed by insulin administration. Levels of aP2 protein were still high, in some cases, 1 day after the decrease in mRNA levels consistent with a long half-life of the protein. Decreases in aP2 protein were rapidly reversed by insulin administration. There were no changes in aP2 protein in the absence of changes in aP2 mRNA supporting a pretranslational mechanism of regulation. The decrease in aP2 mRNA was delayed in onset when compared with the rapid decline (at day 2 of diabetes) of mRNA for the lipogenic enzyme, fatty acid synthase, and with the accelerated depletion of adipose tissue lipid. Adipose tissue weight and lipid content had decreased by more than 80% 3 days before any significant changes in aP2 expression were observed. Changes in aP2 could not be related to changes in the levels of circulating fatty acids that regulate aP2 expression in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
_targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels.J Lipid Res. 1999 May;40(5):967-72. J Lipid Res. 1999. PMID: 10224167
-
Regulation of gene expression in adipose cells by polyunsaturated fatty acids.Adv Exp Med Biol. 1997;422:145-56. doi: 10.1007/978-1-4757-2670-1_12. Adv Exp Med Biol. 1997. PMID: 9361822
-
Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats.Mol Endocrinol. 1992 Dec;6(12):2219-28. doi: 10.1210/mend.6.12.1283442. Mol Endocrinol. 1992. PMID: 1283442
-
Changes in fatty acid transport and transporters are related to the severity of insulin deficiency.Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E612-21. doi: 10.1152/ajpendo.00011.2002. Am J Physiol Endocrinol Metab. 2002. PMID: 12169456
-
Dietary lipids influence insulin action.Ann N Y Acad Sci. 1993 Jun 14;683:151-63. doi: 10.1111/j.1749-6632.1993.tb35701.x. Ann N Y Acad Sci. 1993. PMID: 8352437 Review.
Cited by
-
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases.Clin Med Insights Cardiol. 2015 Feb 2;8(Suppl 3):23-33. doi: 10.4137/CMC.S17067. eCollection 2014. Clin Med Insights Cardiol. 2015. PMID: 25674026 Free PMC article. Review.
-
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.Nature. 2007 Jun 21;447(7147):959-65. doi: 10.1038/nature05844. Epub 2007 Jun 6. Nature. 2007. PMID: 17554340 Free PMC article.
-
Pre-emptive pharmacological inhibition of fatty acid-binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism.Cell Death Dis. 2021 Jun 3;12(6):572. doi: 10.1038/s41419-021-03850-1. Cell Death Dis. 2021. PMID: 34083513 Free PMC article.
-
Regulation of antioxidant enzyme expression by NGF.Neurochem Res. 1997 Apr;22(4):351-62. doi: 10.1023/a:1027387105882. Neurochem Res. 1997. PMID: 9130244
-
Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation.PLoS One. 2014 Jun 11;9(6):e99862. doi: 10.1371/journal.pone.0099862. eCollection 2014. PLoS One. 2014. PMID: 24918907 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials